Advertisement

Topics

Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

08:28 EDT 20 Aug 2017 | BioPortfolio Reports

DelveInsight's, Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease. This report provides information on the therapeutic development for Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinical, preclinical as well as discovery products. The report further contains details on dormant products and discontinued products. Therapeutic assessment of all the active products by route of administration and molecule type is also covered in this report.
The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Alnylam Pharmaceuticals Inc.;Arcturus Therapeutics Inc.;Ionis Pharmaceuticals Inc.;Neurimmune Holding AG;Pfizer Inc.;Prothena Corporation Plc;Regeneron Pharmaceuticals Inc;SOM Biotech SL; Alnylam Pharmaceuticals Inc.; Bsim2; Isis Pharmaceuticals Inc.; Pfizer Inc.; ProteoTech Inc.
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Pipeline Drugs
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Pipeline Assessment
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Pipeline Analysis
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Drugs under Development
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Discovery drugs
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Preclinical drugs
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Phase I drugs
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Phase II drugs
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Phase III Pipeline Drugs Assessment
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Preregistration drugs
Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Molecules in pipeline

Original Article: Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

NEXT ARTICLE

More From BioPortfolio on "Familial Amyloid Polyneuropathy Transthyretin Amyloidosis, Corino de Andrade's Disease Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...